Medinoah
Founded Year
2008Stage
Series B | AliveTotal Raised
$15.46MAbout Medinoah
Medinoah is a technologically drug R&D service company that provides global biomedical companies with R&D services based on synthetic chemistry/analytical chemistry core competitiveness from drug synthesis, screening and structure optimization, production process development, total quality research to cGMP production. The company was founded in 2008 and is based in Suzhou, China.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Medinoah Frequently Asked Questions (FAQ)
When was Medinoah founded?
Medinoah was founded in 2008.
Where is Medinoah's headquarters?
Medinoah's headquarters is located at Room 501, Building C9, Bio-Nano Park, No.218 Xinghu Street, Suzhou Industrial Park, Suzhou.
What is Medinoah's latest funding round?
Medinoah's latest funding round is Series B.
How much did Medinoah raise?
Medinoah raised a total of $15.46M.
Who are the investors of Medinoah?
Investors of Medinoah include Oriza Holdings, Addor Capital, Hankang Equity Investment Management, Zhongxin Innovation Capital, Jiadinghui Equity Investment and 5 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
